18 August 2021 : Clinical Research
Effects of Doxofylline Combined with Ceftazidime on Clinical Efficacy, Drug Safety, and Prognosis in Patients with Chronic Obstructive Pulmonary Disease Complicated with Infection
Ying WangEFGDOI: 10.12659/MSM.930494
Med Sci Monit 2021; 27:e930494
Table 3 Comparison of pulmonary function.
| Group | Case | The peak expiratory flow rate (L/min) | The volume of 1 second’s forced respiration (L) | The maximal mid-expiratory flow curve (ml/s) |
|---|---|---|---|---|
| Observation group | 225 | 0.54±0.29* | 1.59±0.68* | 0.46±0.30* |
| Control group | 225 | 0.28±0.12 | 1.08±0.37 | 0.19±0.12 |
| Blank group | 50 | 0.55±0.14 | 1.61±0.53 | 0.47±0.22 |
| value | 91.6 | 54.84 | 88.25 | |
| value | <0.05 | <0.05 | <0.05 | |
| * Represented compared with Control group P # represented compared with Blank group, P>0.05. | ||||